GlassScriptPhysician profile
Jay J M Lee
NPI 1255795597
$9,351.16
in general payments reported to CMS, 2019-2025
17 companies · $1,934 in 2025
The $1,934 reported for 2025 was more than what 78% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,256 · 2022: $1,108 · 2023: $3,053 · 2024: $1,000 · 2025: $1,934.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,146 · Travel and Lodging: $1,841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,145.93 |
| Travel and Lodging | $1,840.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,201.20 | 2021-2025 | Kyphon Express II Kyphopak Tray, Intellis Adaptivestim, Synchromedii |
| Si-Bone, INC. | $1,009.63 | 2025 | |
| Abbott Laboratories | $257.53 | 2021-2024 | Proclaim |
| Nevro Corp. | $167.67 | 2021 | |
| Spinal Simplicity, LLC | $164.54 | 2023-2025 | Ha Minuteman G3-R |
| Globus Medical, INC. | $104.06 | 2025 | Senza |
| Painteq LLC | $93.35 | 2024 | Painteq |
| Vertos Medical, INC. | $81.19 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $53.59 | 2024-2025 | |
| Abbvie INC. | $50.59 | 2021-2025 | |
| Collegium Pharmaceutical, INC. | $34.95 | 2024 | Xtampza |
| Convatec INC. | $32.16 | 2025 | |
| Boston Scientific Corporation | $23.15 | 2025 | General - Pain Management |
| Averitas Pharma INC. | $22.46 | 2025 | Qutenza |
| Pfizer INC. | $20.66 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $18.06 | 2022 | |
| Stryker Corporation | $16.37 | 2025 | Mild Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.